IL17A and prostate carcinoma: Besides, Insulin and IGF1 enhanced IL-17-induced inflammatory responses through suppressing GSK3 in cultured cell lines and in obese mouse models of prostate cancer indicating crosslink between the insulin receptor pathway and IL-17 signaling [68].